-
1
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disorder, linked to obesity and metabolic dysfunction.
-
2
Electroacupuncture (EA) shows promise as an adjunctive treatment for NAFLD, improving hepatic steatosis and metabolic parameters.
-
3
EA modulates key molecular pathways, including AMPK, SIRT1, PI3K/Akt, and NF-κB, impacting lipid metabolism and inflammation.
-
4
Current management of NAFLD lacks approved pharmacological therapies, emphasizing the need for innovative treatment strategies.
-
5
Emerging therapeutic agents and strategies are under investigation, but long-term safety data and consistent outcomes remain challenges.
